Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is the mortality rate for septic shock really decreasing?

Eirini Christaki1, Steven M Opal

  • 1The Infectious Disease Division, the Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Current Opinion in Critical Care
|September 13, 2008
PubMed
Summary

Mortality rates for septic shock have gradually improved over the past 25 years due to better supportive care. However, these improvements are small, and new therapies are needed for further progress in treating sepsis.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet-Rich Plasma in a Refractory Venous Leg Ulcer Following Multiple Failed Skin Grafts.

International wound journal·2026
Same author

The Gut-Immune Axis in Treated HIV Infection: From Mucosal Damage to Chronic Inflammation and Therapeutic Opportunities-A Clinician-Oriented Narrative Review.

Microorganisms·2026
Same author

Epidemiology and antimicrobial resistance patterns of Aeromonas species in Europe, 2020-2024 (AEuROMONAS).

Diagnostic microbiology and infectious disease·2026
Same author

Host restriction factors and p17-Driven inflammaging in HIV-1: From molecular pathogenesis to functional cure.

AIMS microbiology·2026
Same author

Minor non-fermenting Gram-negative bacilli in Europe, 2020-2024 (MINOFEu).

International journal of antimicrobial agents·2026
Same author

Remdesivir: Real-World Effectiveness and Safety in Individuals Hospitalized for Non-COVID Reasons and Non-Hospitalized High-Risk Patients During the Omicron Era in Greece.

Microorganisms·2026

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Sepsis research

Background:

  • Septic shock remains a significant cause of mortality worldwide.
  • Past treatment strategies may have inadvertently increased mortality.

Purpose of the Study:

  • To analyze trends in septic shock mortality over the last 25 years.
  • To evaluate the effectiveness of interventions and identify areas for improvement.

Main Methods:

  • Systematic review of mortality data for septic shock patients.
  • Analysis of treatment protocols and outcomes over a 25-year period.

Main Results:

  • A slow but statistically significant decrease in septic shock mortality has been observed.

Related Experiment Videos

  • Improvements are largely attributed to enhanced supportive care.
  • Overuse of certain treatments in the past likely contributed to higher mortality.

    • Conclusions:

    • Survival rates for septic shock have incrementally improved globally.
    • Future advancements depend on novel therapies targeting sepsis pathophysiology.
    • Development of rapid diagnostics and immune monitoring is crucial for better patient outcomes.